SBRT With DIBH for HCC After TACE and Lipiodol Marking
Clinical trial NCT05021250 · UNKNOWN
Trial details
- NCT number
- NCT05021250
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-21
- Primary completion
- 2023-12-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.